Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paschen

Showing results (501-510 of 570) with videos related to

Pageof 57
Sort By:
Drug and Alcohol Dependence|March 6, 2024
PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is highMary A Hatch, Tanja C Laschober, Margaret Paschen-Wolff, et al.
The British Journal of Dermatology|December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaJan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
The Journal of Clinical Investigation|April 8, 2009
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivoTadepally Lakshmikanth, Shannon Burke, Talib Hassan Ali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanomaB Schilling, W Sondermann, F Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2015
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetesKarin Åvall, Yusuf Ali, Ingo B Leibiger, et al.
AIDS and Behavior|December 31, 2024
Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network StudySusan Tross, Tanja C Laschober, Margaret Paschen-Wolff, et al.
Cancers|September 9, 2022
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic LesionsAnne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
Nature Communications|June 1, 2017
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesionsAntje Sucker, Fang Zhao, Natalia Pieper, et al.
International Journal of Cancer|June 23, 2022
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumorsAnne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
Cell Reports|June 20, 2019
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in MelanomaBengt Phung, Maciej Cieśla, Adriana Sanna, et al.
Pageof 57

Showing results (501-510 of 570) with videos related to

Sort By:
Pageof 57
Drug and Alcohol Dependence|March 6, 2024
PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is highMary A Hatch, Tanja C Laschober, Margaret Paschen-Wolff, et al.
The British Journal of Dermatology|December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaJan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
The Journal of Clinical Investigation|April 8, 2009
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivoTadepally Lakshmikanth, Shannon Burke, Talib Hassan Ali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanomaB Schilling, W Sondermann, F Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2015
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetesKarin Åvall, Yusuf Ali, Ingo B Leibiger, et al.
AIDS and Behavior|December 31, 2024
Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network StudySusan Tross, Tanja C Laschober, Margaret Paschen-Wolff, et al.
Cancers|September 9, 2022
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic LesionsAnne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
Nature Communications|June 1, 2017
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesionsAntje Sucker, Fang Zhao, Natalia Pieper, et al.
International Journal of Cancer|June 23, 2022
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumorsAnne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
Cell Reports|June 20, 2019
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in MelanomaBengt Phung, Maciej Cieśla, Adriana Sanna, et al.
Pageof 57